NASDAQ: MDCXMedicus Pharma Ltd Stock Ownership - Who owns Medicus Pharma?
Insider buying vs selling
Have Medicus Pharma Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Raza Bokhari | CEO | 2026-09-04 | 2,941,176 | $0.17 | $502.94kBuy |
| Carolyn F. Bonner | CFO;Pres | 2026-09-04 | 1,470,588 | $0.17 | $251.47kBuy |
| Edward J. Brennan | CSci | 2026-09-04 | 588,235 | $0.17 | $100.59kBuy |
| Faisal Mehmud | Med | 2026-09-04 | 1,470,588 | $0.17 | $251.47kBuy |
| Andrew Alasdair Smith | COO | 2026-09-04 | 735,294 | $0.17 | $125.74kBuy |
MDCX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MDCX insiders and whales buy or sell their stock.
MDCX Shareholders
What type of owners hold Medicus Pharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Raza Bokhari | 194.21% | 3,734,349 | $6.12M | Insider |
| Kenneth R. Melani | 172.86% | 3,323,741 | $5.45M | Insider |
| Velocity Fund Partners LP | 172.86% | 3,323,741 | $5.45M | Insider |
| Ajay Raju | 104.01% | 2,000,000 | $3.28M | Insider |
| Carolyn F. Bonner | 77.46% | 1,489,493 | $2.44M | Insider |
| Faisal Mehmud | 76.48% | 1,470,588 | $2.41M | Insider |
| Andrew Alasdair Smith | 38.25% | 735,458 | $1.21M | Insider |
| Edward J. Brennan | 35.09% | 674,735 | $1.11M | Insider |
| James P. Quinlan | 14.26% | 274,147 | $449.60k | Insider |
| Patrick J. Mahaffy | 1.84% | 35,435 | $58.11k | Insider |
MDCX vs General Drug Manufacturer Stocks
Medicus Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.